SCFAs stimulate L-cells to release GLP-1, while Akkermansia and mucosal-supportive microbes enhance enteroendocrine hormone sensitivity
There is no official clinical guidance supporting this combination, and any perceived benefits reported anecdotally online should be interpreted with significant scepticism
In the SURPASS-2 study, the three doses of tirzepatide (5, 10, and 15 mg once weekly) were tested with the GLP-1RA semaglutide (1 mg once weekly) as a comparator in patients not optimally controlled on monotherapy with metformin (71)
While there is no cure for RLS yet, there are many treatment options, ranging from medication to alternative therapies
Liraglutide promotes improvements in objective measures of cognitive dysfunction in individuals with mood disorders
Traditional cutting approaches reduce calories, which reduces metabolic rate, which slows fat loss, which requires further calorie reduction